Divi's Laboratories (DIVISLAB) — Board Meeting

Divi's Laboratories held its 35th AGM on August 11, 2025, passing all six resolutions with strong majorities. The board declared a ₹30 per share dividend (1,500%), totaling ₹796 crores. FY 2024-25 results showed consolidated revenue of ₹9,712 crores, PBT of ₹2,916 crores, and PAT of ₹2,191 crores. The company commenced Phase I operations at its Unit-3 facility near Kakinada, advancing backward integration. Q1 FY2025-26 delivered ₹2,529 crores revenue and ₹545 crores PAT. Directors were re-appointed and secretarial auditors confirmed. Related-party remuneration approval received 87.63% support.

📄 View Original Announcement (PDF)

📊 Stock Analysis — DIVISLAB ✨ Ask AI About This

About Divi's Laboratories Limited (DIVISLAB)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,79,470.03 Cr P/E: 72.4 ROE: 16.6% ROCE: 22.1%

View full DIVISLAB stock details →

📡 Get AI alerts when DIVISLAB files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track DIVISLAB — Free

💡 Ask AI about this filing

"How does this board meeting affect Divi's Laboratories Limited's outlook?" "What did Divi's Laboratories Limited announce on 11 August 2025?" "Is this positive or negative for DIVISLAB?"

Ask AI Free →

📊 More DIVISLAB filings

See all DIVISLAB filings →

🔥 Also filed on 11 August 2025

SHRIRAMFIN Shriram Finance Limited Corporate Action TATAPOWER Tata Power Company Limited Announcement TITAN Titan Company Limited Financial Results TRENT Trent Limited Financial Results BHARTIARTL Bharti Airtel Limited Financial Results SBIN State Bank of India Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when DIVISLAB files new disclosures

Track DIVISLAB filings, board meetings, and corporate actions. Free email alerts at 5 PM.